Your browser doesn't support javascript.
loading
An IgM-like inhalable ACE2 fusion protein broadly neutralizes SARS-CoV-2 variants.
Liu, Juan; Mao, Fengfeng; Chen, Jianhe; Lu, Shuaiyao; Qi, Yonghe; Sun, Yinyan; Fang, Linqiang; Yeung, Man Lung; Liu, Chunmei; Yu, Guimei; Li, Guangyu; Liu, Ximing; Yao, Yuansheng; Huang, Panpan; Hao, Dongxia; Liu, Zibing; Ding, Yu; Liu, Haimo; Yang, Fang; Chen, Pan; Sa, Rigai; Sheng, Yao; Tian, Xinxin; Peng, Ran; Li, Xue; Luo, Junmian; Cheng, Yurui; Zheng, Yule; Lin, Yongqing; Song, Rui; Jin, Ronghua; Huang, Baoying; Choe, Hyeryun; Farzan, Michael; Yuen, Kwok-Yung; Tan, Wenjie; Peng, Xiaozhong; Sui, Jianhua; Li, Wenhui.
Afiliação
  • Liu J; National Institute of Biological Sciences, Beijing, China.
  • Mao F; Huahui Health Ltd, Beijing, China.
  • Chen J; Huahui Health Ltd, Beijing, China.
  • Lu S; Huahui Health Ltd, Beijing, China.
  • Qi Y; National Kunming High-level Biosafety Primate Research Center, Institute of Medical Biology, Chinese Academy of Medical Sciences and Peking Union Medical College, Yunnan, China.
  • Sun Y; Huahui Health Ltd, Beijing, China.
  • Fang L; National Institute of Biological Sciences, Beijing, China.
  • Yeung ML; National Institute of Biological Sciences, Beijing, China.
  • Liu C; Department of Microbiology, School of Clinical Medicine, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Yu G; State Key Laboratory of Emerging Infectious Diseases, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Li G; Department of Clinical Microbiology and Infection Control, The University of Hong Kong-Shenzhen Hospital, Shenzhen, Guangdong Province, China.
  • Liu X; Carol Yu Centre for Infection, Li Ka Shing Faculty of Medicine, The University of Hong Kong, Hong Kong Special Administrative Region, China.
  • Yao Y; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong Special Administrative Region, China.
  • Huang P; Huahui Health Ltd, Beijing, China.
  • Hao D; Huahui Health Ltd, Beijing, China.
  • Liu Z; Huahui Health Ltd, Beijing, China.
  • Ding Y; National Institute of Biological Sciences, Beijing, China.
  • Liu H; Huahui Health Ltd, Beijing, China.
  • Yang F; Huahui Health Ltd, Beijing, China.
  • Chen P; Huahui Health Ltd, Beijing, China.
  • Sa R; Huahui Health Ltd, Beijing, China.
  • Sheng Y; Huahui Health Ltd, Beijing, China.
  • Tian X; Huahui Health Ltd, Beijing, China.
  • Peng R; Huahui Health Ltd, Beijing, China.
  • Li X; Huahui Health Ltd, Beijing, China.
  • Luo J; Huahui Health Ltd, Beijing, China.
  • Cheng Y; National Institute of Biological Sciences, Beijing, China.
  • Zheng Y; National Institute of Biological Sciences, Beijing, China.
  • Lin Y; Huahui Health Ltd, Beijing, China.
  • Song R; Huahui Health Ltd, Beijing, China.
  • Jin R; Huahui Health Ltd, Beijing, China.
  • Huang B; Huahui Health Ltd, Beijing, China.
  • Choe H; Huahui Health Ltd, Beijing, China.
  • Farzan M; Huahui Health Ltd, Beijing, China.
  • Yuen KY; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Tan W; Beijing Ditan Hospital, Capital Medical University, Beijing, China.
  • Peng X; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention (China CDC), Beijing, China.
  • Sui J; Department of Immunology and Microbiology, Scripps Research, Jupiter, FL, USA.
  • Li W; Department of Immunology and Microbiology, Scripps Research, Jupiter, FL, USA.
Nat Commun ; 14(1): 5191, 2023 08 25.
Article em En | MEDLINE | ID: mdl-37626079
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / COVID-19 Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Enzima de Conversão de Angiotensina 2 / COVID-19 Limite: Animals / Humans / Male Idioma: En Ano de publicação: 2023 Tipo de documento: Article